Delivery Order SPE2DB22D3301-SPE2DB26FX4KC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,448.04 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/mL solution in 100 mL packs, with an ultimate completion date of November 20, 2025. This non-competitive delivery order represents a firm fixed price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,412.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the vendor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,682.50 delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for Epidiolex 100 mg/ml solution in 100 ml packs, with a completion date of October 29, 2025. This competitively awarded, firm fixed-price order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack. The contract was competitively awarded without set-aside designation under firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.75 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $3,720.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 milliliters of Epidiolex 100 mg/ml solution on November 5, 2025, with completion targeted for November 28, 2025. This is a non-set-aside delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packaging, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction and leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at...
- The Defense Logistics Agency awarded a $2,523.75 delivery order to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, will supply this...
- The Defense Logistics Agency awarded a $1,682.50 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epidiolex 100 mg/ml solution in a 100 ml pack. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,190.00 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. The contract is a firm fixed price delivery order with an ultimate completion date of October 20, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4KCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,412.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/mL solution in 100 mL packs, with an ultimate completion date of November 28, 2025. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical supply needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Epidiolex order supports the Defense Health Agency and other federal healthcare systems' ongoing pharmaceutical requirements, demonstrating the company's role as a critical vendor in the government's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 11/5/25 |